Le Lézard
Classified in: Health
Subjects: EXE, VET

Statement by Louise Bradley, President and CEO of the Mental Health Commission to mark Remembrance Day



OTTAWA, Nov. 10, 2017 /CNW/ - "On Remembrance Day, we recognize the sacrifice of Veterans killed in action and those wounded in the service of Canada, many living with the physical and mental scars of war. At the Mental Health Commission of Canada we are committed to improving the mental health of Veterans and their families.

While much work remains to be done, important advances have been made. It has been our privilege to collaborate with Veterans Affairs Canada over the years.

Most recently, we were honored to be part of the Veterans Affairs Health Advisory Group which helped develop a joint suicide prevention strategy for service members and Veterans. Service members are particularly vulnerable as they transition from active duty to civilian life and the joint nature of the strategy, unveiled this October, addresses a significant gap in supports. We were also pleased to work with Veterans Affairs to tailor the Mental Health First Aid program to address the needs of Veterans and the people who care for, and about, them.

On November 11, as the Mental Health Commission of Canada participates in the wreath laying at the national service on Parliament Hill, we renew our dedication to working toward better mental health for Veterans and their families."

THE MENTAL HEALTH COMMISSION OF CANADA
The Mental Health Commission of Canada is a catalyst for change. We are collaborating with hundreds of partners to change the attitudes of Canadians toward mental health problems and to improve services and support. Our goal is to help people who live with mental health problems and illnesses lead meaningful and productive lives. Together we create change. The Mental Health Commission of Canada is funded by Health Canada.
www.mentalhealthcommission.ca | strategy.mentalhealthcommission.ca

Sign up for the MHCC Newsletter

 

SOURCE Mental Health Commission of Canada


These press releases may also interest you

at 13:30
One Drop, a leader in the development of digital therapeutics solutions for people with diabetes, today announced the launch of Blood Glucose Prediction and Automated Decision Support. Through these new features, the One Drop | Mobile app will...

at 13:01
New research finds that people with type 1 diabetes (T1D) who used the Diabeloop DBLG1 therapeutic, closed-loop insulin delivery system in a home setting experienced a greater percentage of time in the target blood glucose range and fewer...

at 12:43
When adolescents and adults with type 1 diabetes (T1D) used a new continuous glucose monitoring (CGM) device containing a sensor that can remain implanted in the arm for up to 180 days, the system provided accurate glucose measurement with no major...

at 12:43
A dual-hormone, artificial pancreas1 delivering rapid insulin and the drug pramlintide improved glucose control and reduced glucose variability in adults with type 1 diabetes (T1D) compared to an insulin-only, first-generation artificial pancreas,...

at 12:40
Adults with type 1 diabetes using the Omnipod hybrid closed-loop system (the Horizontm Automated Glucose Control System) were studied in a supervised outpatient hotel setting with unrestricted meals and moderate-intensity exercise and  experienced...

at 10:12
Adults with type 2 diabetes treated with Tresiba® (insulin degludec injection) had a significant reduction in HbA1c and a 30% lower rate of hypoglycaemic episodes after starting basal insulin Findings from CONFIRM - a large real-world evidence (RWE)...




News published on 10 november 2017 at 14:42 and distributed by: